Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 19927342)

1.

IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis.

Martínez-Cordero E, Trejo AP, León DE.

J Clin Lab Anal. 2009;23(6):408-16. doi: 10.1002/jcla.20342.

PMID:
19927342
2.

Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides.

Kuwana M, Medsger TA Jr, Wright TM.

Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 1):266-78.

PMID:
7554448
3.

Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.

Hayakawa I, Hasegawa M, Takehara K, Sato S.

Arch Dermatol Res. 2005 Oct;297(4):180-3. Epub 2005 Oct 26.

PMID:
16180014
4.

A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera.

Verheijen R, de Jong BA, van Venrooij WJ.

Clin Exp Immunol. 1992 Sep;89(3):456-60.

5.

Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.

Hénault J, Tremblay M, Clément I, Raymond Y, Senécal JL.

Arthritis Rheum. 2004 Oct;50(10):3265-74.

6.

Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system.

Whyte J, Earnshaw WC, Champoux JJ, Parker LH, Stewart L, Hall ND, McHugh NJ.

Clin Exp Immunol. 1995 May;100(2):214-8.

7.
8.

IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.

García de la Peña-Lefebvre P, Chanseaud Y, Tamby MC, Reinbolt J, Batteux F, Allanore Y, Kahan A, Meyer O, Benveniste O, Boyer O, Guillevin L, Boissier MC, Mouthon L.

Clin Immunol. 2004 Jun;111(3):241-51.

PMID:
15183145
9.

Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.

Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM.

Arthritis Rheum. 1999 Mar;42(3):465-74.

10.

Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.

Simon D, Czömpöly T, Berki T, Minier T, Peti A, Tóth E, Czirják L, Németh P.

Int Immunol. 2009 Apr;21(4):415-22. doi: 10.1093/intimm/dxp008. Epub 2009 Feb 11.

11.

Molecular recognition patterns of serum anti-DNA topoisomerase I antibody in systemic sclerosis.

Hu PQ, Fertig N, Medsger TA Jr, Wright TM.

J Immunol. 2004 Aug 15;173(4):2834-41.

12.

Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis.

Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Yazawa N, Tamaki K.

Br J Dermatol. 2004 Oct;151(4):803-8.

PMID:
15491420
13.

Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides.

Seelig HP, Schröter H, Ehrfeld H, Renz M.

J Immunol Methods. 1993 Oct 15;165(2):241-52.

PMID:
8228274
14.
16.

Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity.

McHugh NJ, Whyte J, Harvey G, Haustein UF.

Arthritis Rheum. 1994 Aug;37(8):1198-205.

PMID:
8053959
17.
18.

Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.

Henry PA, Atamas SP, Yurovsky VV, Luzina I, Wigley FM, White B.

Arthritis Rheum. 2000 Dec;43(12):2733-42.

19.

Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.

Hayakawa I, Hasegawa M, Takehara K, Sato S.

Arthritis Rheum. 2004 Jan;50(1):227-32.

20.

Significant elevation of IgG anti-WRN (RecQ3 RNA/DNA helicase) antibody in systemic sclerosis.

Goto M, Okawa-Takatsuji M, Aotsuka S, Nakai H, Shimizu M, Goto H, Shimamoto A, Furuichi Y.

Mod Rheumatol. 2006;16(4):229-34.

PMID:
16906373
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk